3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025Zacks Investment Research • 12/17/24
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?The Motley Fool • 12/17/24
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/09/24
CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 12/09/24
Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?Zacks Investment Research • 12/05/24
Wall Street Analysts Think CRISPR Therapeutics (CRSP) Could Surge 58.3%: Read This Before Placing a BetZacks Investment Research • 12/02/24
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%The Motley Fool • 11/30/24
CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)Seeking Alpha • 11/21/24
CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell?Zacks Investment Research • 11/20/24
CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)Seeking Alpha • 11/15/24
Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?Zacks Investment Research • 11/06/24
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial ResultsGlobeNewsWire • 11/05/24
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving AverageZacks Investment Research • 11/04/24
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 11/04/24